Clinical Trial Update: Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating imatinib mesylate with or without hydroxychloroquine in chronic myeloid leukemia; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Imatinib mesylate (Imatinib)

Snippet

Sponsor: Lynn McMahon | Conditions: Leukemia | Phase 2 | Status: UNKNOWN